
Amissa Health develops digital biomarkers for the early diagnosis, prediction and prevention of Alzheimer’s disease and related dementias.

Amissa Health develops digital biomarkers for the early diagnosis, prediction and prevention of Alzheimer’s disease and related dementias.
Founded: 2017
Headquarters: Charlotte, North Carolina
Focus: Digital biomarkers and clinical intelligence for menopause/perimenopause care
Employees: 13
Total funding: USD 3,810,000 (grants included)
Women’s midlife health (perimenopause/menopause) and digital biomarkers for neurodegenerative disease research.
2017
Digital health; women’s health
Grant funding event recorded and closed on this date.